Xenometrix signs European distribution deals:
This article was originally published in Clinica
Xenometrix has signed a series of agreements for distribution of its molecular information assay systems in Europe and Asia. Biogenic will distribute the company's products in France; Merlin Diagnostics in Germany; and Stag in Belgium. Seoulin Scientific will handle distribution in Korea.
You may also be interested in...
The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.